Melvin Cheitlin

University of California at San Francisco, School of Medicine, United States of America

Melvin Cheitlin is Emeritus Professor of Medicine at UCSF since 1997.

His research interests include cardiovascular involvement in AIDS, valvular heart disease, and severe tricuspid regurgitation

Throughout his career, Professor Cheitlin has received many awards for hs outstanding achievements. He was, for example, awarded the title "Master of the American College of Cardiology" (MACC) in 1998 and Distinguished Fellow of the Society of Geriatric Cardiology. In 1999, he received the Special Recognition Award by the Laennec Society of the AHA Council on Clinical Cardiology. And in 2004, he received the Cardiology Faculty Special Award by Division of Cardiology at UCSF.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Cardiovascular Disorders > Geriatric Cardiology (since 19 September 2007)

All recent recommendations

• 6.6
  Rosuvastatin in older patients with systolic heart failure.
  Recommended by Jerome Fleg, Wilbert Aronow, Melvin Cheitlin
  
• 3.2
  Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
  Recommended by Mariell Jessup, Melvin Cheitlin
  
• 6.0
  Management of prosthetic valve infective endocarditis.
  Recommended by Melvin Cheitlin
  
• 3.0
  CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.
  Recommended by Melvin Cheitlin
  
• 9.0
  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
  Recommended by Melvin Cheitlin
  
• 3.0
  Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
  Recommended by Melvin Cheitlin
  
• 9.0
  Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life.
  Recommended by Melvin Cheitlin
  
• 9.0
  Protective effect of long-term angiotensin II inhibition.
  Recommended by Melvin Cheitlin
  
• 3.0
  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.
  Recommended by Melvin Cheitlin
  
• 8.0
  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
  Recommended by Melvin Cheitlin, Ralph Corey